Trifecta Capital Advisors LLC Has $6.22 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trifecta Capital Advisors LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 12,566 shares of the medical equipment provider's stock after purchasing an additional 1,052 shares during the quarter. Intuitive Surgical comprises approximately 1.3% of Trifecta Capital Advisors LLC's investment portfolio, making the stock its 27th largest holding. Trifecta Capital Advisors LLC's holdings in Intuitive Surgical were worth $6,224,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Norges Bank purchased a new position in Intuitive Surgical during the 4th quarter worth $2,401,493,000. GAMMA Investing LLC boosted its holdings in Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC boosted its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Capital Research Global Investors boosted its holdings in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Intuitive Surgical during the 4th quarter worth $313,769,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Citigroup reiterated a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Truist Financial lowered their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Royal Bank Of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Trading Down 0.5%

Shares of ISRG opened at $509.49 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The stock's 50 day moving average is $527.31 and its two-hundred day moving average is $537.92. The firm has a market cap of $182.61 billion, a P/E ratio of 74.71, a PEG ratio of 5.43 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the company posted $1.50 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.